相关实验视频
Updated: Jul 19, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.9K
用HYPO-CHEAT降低低血糖症的成功试点背后的行为变化
Chris Worth1,2, Paul W Nutter1, Maria Salomon-Estebanez2
1Department of Computer Science, University of Manchester, Manchester, UK.
Digital health
|August 7, 2023
概括
这项研究引入了HYPO-CHEAT,一种使用连续血糖监测数据的新技术,以帮助患有先天性高胰岛素症 (CHI) 的儿童主动预防低血糖症. 该方法通过将葡萄糖模式与行为联系起来,成功降低了低血糖症,从而实现了个性化预防策略.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 行为科学 行为科学
- 医疗信息学 医疗信息学
背景情况:
- 在儿童中,先天性高胰岛素症 (CHI) 构成低血糖和潜在脑损伤的持续风险.
- 目前的低血糖管理依赖于反应性措施,并且由于忽视行为因素,机器学习 (ML) 预测的成功有限.
- 说服性技术 (PT) 为基于理论的,技术先进的低血糖预防提供了一个有前途的途径.
研究的目的:
- 开发一种PT干预措施,以积极预防CHI儿童的低血糖症.
- 通过从反应性转向主动性战略,解决当前低血糖管理中的障碍.
主要方法:
- 开发了HYPO-CHEAT (低血糖-预防-通过-Cgm-热图辅助技术),利用行为改变技术和说服力系统设计.
- 集成连续血糖监测 (CGM) 数据成易于解释的可视化,以促进行为变化.
- 在10名患有CHI的儿科患者中试验HYPO-CHEAT超过12周.
主要成果:
- 成功确定了与特定行为相关的每周低血糖模式.
- 观察到综合低血糖症的显著减少,从7.1%降至5.4%.
- 五分之四的患者表现出临床上有意义的降低低血糖,随着指针刺伤行为的变化.
结论:
- HYPO-CHEAT代表了一种新的,个性化的方法,用于在患有CHI的儿童中积极预防低血糖.
- 这种以技术为导向,以行为为重点的策略标志着在这个脆弱人群中管理低血糖症方面迈出了重要的一步.
相关概念视频
Hypoglycemia and Glucagon
297
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
297
SBAR II: Application of SBAR
4.5K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.5K
Hormones Regulating Blood Glucose
3.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.5K
Glucose Homeostasis: Regulation of Blood Glucose
1.8K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.8K
Diabetes: Management and Pharmacotherapy
311
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
311
Insulin: Dosing Regimen and Adverse Effects
207
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
207

